Breast implant recalls | 合法醫療器材資訊網

2020年6月3日—Allerganistryingtotrackdownwomenwithbreastimplantsitrecalled...ManywomenaffectedbyAllergan'sBiocellrecalltoldFortunethattheyfoundout...FORTUNEmayreceivecompensationforsomelinkstoproductsand ...

More than 10 months after recalling some of its breast implants[1], Allergan is making a new effort to find tens of thousands of women who still have the dangerous devices.

The pharmaceutical company, now owned by AbbVie[2], said[3] this week that it will launch a digital and social media ad campaign to alert patients about the July 2019 recall of its textured Biocell implants. Those implants have been linked in academic studies to a sometimes-fatal cancer known as BIA-ALCL, for “breast implant–associated anaplastic large cell lymphoma.” More than 33 women have now died from BIA-ALCL.

Allergan’s announcement comes two weeks after Fortune published an investigation[4] into the persistent problems with breast implants and the health risks, including BIA-ALCL, they have created for millions of women worldwide. These risks have been amplified by decades of inadequate study and problems that were ...